sec filing
DA
NASDAQ · DARE
Daré Bioscience, Inc.
Healthcare · Biotechnology
$0.82
Up+$0.07 (+8.67%)
Updated Sep 30, 2026, 11:53 AM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 19.81M
- P/E ratio
- -1.52
- Dividend yield
- 0.00%
- 52-week range
- $0.69 – $3.78
- Volume
- 644.39K
- Avg. volume
- 140.35K
Price performance · DARE
DARE price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Sep 29, 2026
DARE closed at $0.82 after 20 trading sessions, up 5.82% for the selected period.
- Last close
- $0.82
- Period change
- +5.82%
- Period low
- $0.71
- Period high
- $0.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 29, 2026 | $0.7869 | $0.8671 | $0.7356 | $0.815 | 644.39K |
| Sep 28, 2026 | $0.79 | $0.816 | $0.7012 | $0.75 | 698.47K |
| Sep 25, 2026 | $0.77 | $0.7895 | $0.7458 | $0.7755 | 119.24K |
| Sep 24, 2026 | $0.8023 | $0.8456 | $0.7117 | $0.7405 | 469.51K |
| Sep 23, 2026 | $0.85 | $0.8699 | $0.80 | $0.8074 | 100.04K |
| Sep 22, 2026 | $0.81 | $0.88 | $0.8099 | $0.85 | 245.72K |
| Sep 21, 2026 | $0.82 | $0.8399 | $0.796 | $0.81 | 279.93K |
| Sep 18, 2026 | $0.7925 | $0.81 | $0.7655 | $0.7843 | 229.16K |
| Sep 17, 2026 | $0.7445 | $0.7759 | $0.7445 | $0.7478 | 153.93K |
| Sep 16, 2026 | $0.732 | $0.7593 | $0.724 | $0.7255 | 135.5K |
| Sep 15, 2026 | $0.7413 | $0.7713 | $0.72 | $0.7301 | 109.23K |
| Sep 14, 2026 | $0.7064 | $0.75 | $0.691 | $0.7363 | 426.37K |
| Sep 11, 2026 | $0.717 | $0.7233 | $0.705 | $0.706 | 93.72K |
| Sep 10, 2026 | $0.70 | $0.7247 | $0.70 | $0.7051 | 103.44K |
| Sep 9, 2026 | $0.729 | $0.7299 | $0.691 | $0.7166 | 175.32K |
| Sep 8, 2026 | $0.7299 | $0.737 | $0.701 | $0.713 | 191.71K |
| Sep 4, 2026 | $0.70 | $0.7573 | $0.70 | $0.721 | 437.48K |
| Sep 3, 2026 | $0.7512 | $0.779 | $0.69 | $0.7131 | 450.3K |
| Sep 2, 2026 | $0.78 | $0.797 | $0.74 | $0.74 | 249.08K |
| Sep 1, 2026 | $0.744 | $0.797 | $0.7301 | $0.7702 | 462.69K |
Latest DARE news
The latest Smart Investors Daily articles mentioning DARE.
Stock researchResearch & News · SEC Filings
Company
OverviewForecastEarnings — requires Earnings Calls and Results accessDividend — requires Dividend Research accessFinancials
Market Activity
OptionsInsider Trades — requires Insider Buying and Selling accessShort InterestInstitutional Ownership — requires Institutional Ownership accessSentiment
Research & News
Loading stock research…